Cite
HARVARD Citation
Schillemans, M. et al. (2019). Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells. Research and practice in thrombosis and haemostasis. 3 (4), pp. 718-732. [Online].